Earlier quoted context omitted.
Have you not had a family member or close friend cured of disease that would have killed them a hundred years ago, thanks to modern pharma drug? I sure have.
No, not personally, I do have 2 on life long treatments. But I was being too hyperbolic and I don't doubt your story. I'm just extrapolating incentives. Is there any incentive to cure (invoice once), when they can treat (life long invoices)? Certainly scorn is irrelevant as OPs comment suggests they're unwilling to work on rare diseases. And these companies are public. They have shareholders that expect them to const…
You know many people who would have died of smallpox,measles, polio, and the like 100 years ago, you just have no idea who those people are.